{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:58:35Z","timestamp":1791287915003,"version":"4.3.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.molmet.2020.101111","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:00:44Z","timestamp":1604581244000},"page":"101111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["Genetic and epigenetic factors determining NAFLD risk"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-9200","authenticated-orcid":false,"given":"Wenke","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2020.101111_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14600","article-title":"The association of non-alcoholic fatty liver disease and cardiac structure and function\u2014Framingham Heart Study","author":"Chiu","year":"2020","journal-title":"Liver International"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21939-0","article-title":"Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy","volume":"8","author":"Di Costanzo","year":"2018","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/db15-1716","article-title":"Hepatic DPP4 DNA methylation associates with fatty liver","volume":"66","author":"Baumeier","year":"2017","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib9","first-page":"2588","article-title":"Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice","volume":"25","author":"Kammel","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/j.molmet.2020.101111_bib10","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and liver fibrosis","volume":"4","author":"Moran-Salvador","year":"2017","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI127502","article-title":"Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice","volume":"130","author":"de Jesus","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ijo.2015.13","article-title":"Epigenomics, gestational programming and risk of metabolic syndrome","volume":"39","author":"Desai","year":"2015","journal-title":"International Journal of Obesity"},{"issue":"7","key":"10.1016\/j.molmet.2020.101111_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021662","article-title":"Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation","volume":"6","author":"Dudley","year":"2011","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib19","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.23205","article-title":"Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression","volume":"50","author":"Bruce","year":"2009","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/j.molmet.2020.101111_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-013-1294-3","article-title":"Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan","volume":"132","author":"Kitamoto","year":"2013","journal-title":"Human Genetics"},{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genetics"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/21623945.2019.1607423","article-title":"PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease","volume":"8","author":"Basuray","year":"2019","journal-title":"Adipocyte"},{"key":"10.1016\/j.molmet.2020.101111_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbalip.2018.06.018","article-title":"The role of PNPLA3 in health and disease","author":"Pingitore","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"41","key":"10.1016\/j.molmet.2020.101111_bib25","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib26","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2020.101111_bib27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00125-014-3310-0","article-title":"PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans","volume":"57","author":"Peter","year":"2014","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib28","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib30","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"17","key":"10.1016\/j.molmet.2020.101111_bib33","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A\u00a0feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib34","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00125.2011","article-title":"PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis","volume":"302","author":"Perttil\u00e4","year":"2012","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jhep.2009.11.004","article-title":"The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status","volume":"52","author":"Hoekstra","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","article-title":"Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption","volume":"92","author":"Davis","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.molmet.2020.101111_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fmed.2019.00304","article-title":"PNPLA3\u2014a potential therapeutic target for personalized treatment of chronic liver disease","volume":"6","author":"Dong","year":"2019","journal-title":"Frontiers of Medicine"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"Journal of Lipid Research"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jhep.2016.06.029","article-title":"Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy","volume":"65","author":"Lin","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib40","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"19","key":"10.1016\/j.molmet.2020.101111_bib41","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1073\/pnas.1901974116","article-title":"Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis","volume":"116","author":"Basuray","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib42","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.molmet.2020.101111_bib43","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"23","key":"10.1016\/j.molmet.2020.101111_bib44","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib45","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/liv.14507","article-title":"The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue","volume":"40","author":"Qadri","year":"2020","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jgh.12714","article-title":"A\u00a0common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Zain","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"21","key":"10.1016\/j.molmet.2020.101111_bib48","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00125-007-0865-z","article-title":"The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes","volume":"51","author":"Spars\u00f8","year":"2008","journal-title":"Diabetologia"},{"issue":"5829","key":"10.1016\/j.molmet.2020.101111_bib50","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"316","author":"Saxena","year":"2007","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9120282","article-title":"Glucose-6 phosphate, A central hub for liver carbohydrate metabolism","volume":"9","author":"Rajas","year":"2019","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib55","first-page":"1","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"Holmen","year":"2014","journal-title":"Nature Genetics"},{"issue":"24","key":"10.1016\/j.molmet.2020.101111_bib57","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib59","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","article-title":"Phosphatidylcholine biosynthesis and lipoprotein metabolism","volume":"1821","author":"Cole","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib60","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1038\/s41598-019-47737-w","article-title":"The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids","volume":"9","author":"Prill","year":"2019","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib61","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A\u00a0protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1194\/jlr.P089953","article-title":"Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease","volume":"60","author":"Pirola","year":"2019","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132158","article-title":"Hydroxysteroid 17-\u03b2 dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease","volume":"5","author":"Luukkonen","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib64","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.30350","article-title":"17-Beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease","volume":"69","author":"Ma","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2020.101111_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2018.10.014","article-title":"Role of HSD17B13 in the liver physiology and pathophysiology","volume":"489","author":"Su","year":"2019","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.molmet.2020.101111_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pharmthera.2019.01.006","article-title":"Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders","volume":"197","author":"Blaner","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.molmet.2020.101111_bib67","first-page":"320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","author":"Thangapandi","year":"2020","journal-title":"Gut: Gutjnl"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib68","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A\u00a0genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib69","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2020.101111_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound o-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"ELife"},{"issue":"44","key":"10.1016\/j.molmet.2020.101111_bib71","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1074\/jbc.M806194200","article-title":"Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils","volume":"283","author":"Gij\u00f3n","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib72","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/j.molmet.2020.101111_bib74","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-0329","article-title":"Role of patatin-like phospholipase domain\u2013containing 3 gene for hepatic lipid content and insulin resistance in diabetes","author":"Zaharia","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000346195","article-title":"Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity","volume":"75","author":"Gorden","year":"2013","journal-title":"Human Heredity"},{"key":"10.1016\/j.molmet.2020.101111_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mam.2015.09.002","article-title":"Role of glycogen phosphorylase in liver glycogen metabolism","volume":"46","author":"Agius","year":"2015","journal-title":"Molecular Aspects of Medicine"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib77","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.29751","article-title":"Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride","volume":"67","author":"Stender","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib78","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa151","article-title":"Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose","volume":"105","author":"Seidelin","year":"2020","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"25","key":"10.1016\/j.molmet.2020.101111_bib79","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1074\/jbc.M116.766329","article-title":"Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis","volume":"292","author":"Mehta","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2017.02.037","article-title":"The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children","volume":"67","author":"Bellini","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib81","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/liv.14039","article-title":"The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study","volume":"39","author":"Simon","year":"2019","journal-title":"Liver International"},{"key":"10.1016\/j.molmet.2020.101111_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.04.031","article-title":"Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation","author":"Schwerbel","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/labinvest.2010.166","article-title":"Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease","volume":"91","author":"Alisi","year":"2011","journal-title":"Laboratory Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib84","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MPG.0b013e3182442a55","article-title":"LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease","volume":"54","author":"Valenti","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib85","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2337\/db08-0422","article-title":"Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. populations","volume":"57","author":"Fawcett","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2004.12.002","article-title":"Lipin, a lipodystrophy and obesity gene","volume":"1","author":"Phan","year":"2005","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cld.710","article-title":"The epidemiology of nonalcoholic steatohepatitis","volume":"11","author":"Younossi","year":"2018","journal-title":"Clinical Liver Disease"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib89","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPG.0000000000000279","article-title":"A\u00a04-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease","volume":"58","author":"Nobili","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib90","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2011.05.029","article-title":"The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies","volume":"56","author":"Al-Serri","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib91","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.04.004","article-title":"The kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease","volume":"135","author":"Miele","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2020.101111_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.02.011","article-title":"Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in asian patients with nonalcoholic fatty liver disease","author":"Koo","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib93","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.dld.2019.05.029","article-title":"Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents","volume":"51","author":"Zusi","year":"2019","journal-title":"Digestive and Liver Disease"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib94","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib95","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1096\/fj.10-170365","article-title":"A\u00a0dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss","volume":"25","author":"Milagro","year":"2011","journal-title":"The FASEB Journal"},{"issue":"10","key":"10.1016\/j.molmet.2020.101111_bib96","doi-asserted-by":"crossref","first-page":"E912","DOI":"10.1152\/ajpendo.00289.2014","article-title":"Exercise training alters DNA methylation patterns in genes related to muscle growth and differentiation in mice","volume":"308","author":"Kanzleiter","year":"2015","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib97","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.celrep.2013.03.018","article-title":"Weight loss after gastric bypass surgery in human obesity remodels promoter methylation","volume":"3","author":"Barres","year":"2013","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12081-0","article-title":"Dynamic changes of muscle insulin sensitivity after metabolic surgery","volume":"10","author":"Gancheva","year":"2019","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI69740","article-title":"Characterizing DNA methylation alterations from the cancer genome atlas","volume":"124","author":"Weisenberger","year":"2014","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","article-title":"Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"7","author":"Zeybel","year":"2015","journal-title":"Clinical Epigenetics"},{"issue":"7","key":"10.1016\/j.molmet.2020.101111_bib102","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib103","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23927","article-title":"Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 promoter","volume":"52","author":"Sookoian","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib104","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/oby.2008.605","article-title":"Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns","volume":"17","author":"Gemma","year":"2009","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1022518321634","article-title":"Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women","volume":"14","author":"Allen","year":"2003","journal-title":"Cancer Causes & Control"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"International Journal of Obesity"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/db18-0620","article-title":"Insulin-like growth factor binding protein 2 (IGFBP-2) and the risk of developing type 2 diabetes","volume":"68","author":"Wittenbecher","year":"2019","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib108","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.3390\/ijms21114144","article-title":"Physiological disturbance in fatty liver energy metabolism converges on IGFBP2 abundance and regulation in mice and men","volume":"21","author":"Fahlbusch","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI30076","article-title":"The role of gut hormones in glucose homeostasis","volume":"117","author":"Drucker","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib110","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/dc13-0496","article-title":"Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in\u00a0vivo and in\u00a0vitro","volume":"36","author":"Sell","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib111","first-page":"729","article-title":"Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Molecular Medicine Reports"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib112","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00125-018-4595-1","article-title":"Dietary carbohydrates impair the protective effect of protein restriction against diabetes in NZO mice used as a model of type 2 diabetes","volume":"61","author":"Laeger","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2020.101111_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jnutbio.2018.09.025","article-title":"Epigenetic regulation of hepatic Dpp4 expression in response to dietary protein","volume":"63","author":"Saussenthaler","year":"2019","journal-title":"Journal of Nutritional Biochemistry"},{"issue":"5","key":"10.1016\/j.molmet.2020.101111_bib114","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2337\/db18-1193","article-title":"A\u00a0peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease","volume":"68","author":"Ma","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2020.101111_bib115","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.12659\/MSM.909747","article-title":"Altered DNA methylation sites in peripheral blood leukocytes from patients with simple steatosis and nonalcoholic steatohepatitis (NASH)","volume":"24","author":"Wu","year":"2018","journal-title":"Medical Science Monitor"},{"issue":"5\u20136","key":"10.1016\/j.molmet.2020.101111_bib116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00335-020-09835-3","article-title":"Epigenetic contribution to obesity","volume":"31","author":"Ouni","year":"2020","journal-title":"Mammalian Genome"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib117","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"7308","key":"10.1016\/j.molmet.2020.101111_bib118","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib119","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"MiR-122 - a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"36","key":"10.1016\/j.molmet.2020.101111_bib120","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World Journal of Gastroenterology"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib121","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific MicroRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Current Biology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","article-title":"A\u00a0feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation","volume":"142","author":"Laudadio","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib123","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in\u00a0vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib124","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ijo.2017.21","article-title":"Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD","volume":"41","author":"Latorre","year":"2017","journal-title":"International Journal of Obesity"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs-122,-192 and-21 as biomarkers in patients with non-Alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.molmet.2020.101111_bib126","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"14","key":"10.1016\/j.molmet.2020.101111_bib127","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1042\/CS20160216","article-title":"Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury","volume":"130","author":"Roy","year":"2016","journal-title":"Clinical Science"},{"issue":"25","key":"10.1016\/j.molmet.2020.101111_bib128","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1074\/jbc.M117.785592","article-title":"An HNF4\u03b1\u2013microRNA-194\/192 signaling axis maintains hepatic cell function","volume":"292","author":"Morimoto","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2020.101111_bib129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/BJ20111861","article-title":"Transforming growth factor \u03b21 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding","volume":"443","author":"Jenkins","year":"2012","journal-title":"Biochemical Journal"},{"issue":"9","key":"10.1016\/j.molmet.2020.101111_bib130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","article-title":"The ZEB\/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?","volume":"11","author":"Brabletz","year":"2010","journal-title":"EMBO Reports"},{"issue":"7","key":"10.1016\/j.molmet.2020.101111_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10071040","article-title":"MicroRNAs and their influence on the zeb family: mechanistic aspects and therapeutic applications in cancer therapy","volume":"10","author":"Ashrafizadeh","year":"2020","journal-title":"Biomolecules"},{"issue":"48","key":"10.1016\/j.molmet.2020.101111_bib132","doi-asserted-by":"crossref","first-page":"12158","DOI":"10.1073\/pnas.1808855115","article-title":"Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice","volume":"115","author":"Casta\u00f1o","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7369","key":"10.1016\/j.molmet.2020.101111_bib133","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib134","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1042\/bst0301091","article-title":"Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis","volume":"30","author":"Horton","year":"2002","journal-title":"Biochemical Society Transactions"},{"issue":"40","key":"10.1016\/j.molmet.2020.101111_bib135","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in\u00a0vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"10.1016\/j.molmet.2020.101111_bib136","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012609","article-title":"Identification of differential roles of microRNA-33a and -33b during atherosclerosis progression with genetically modified mice","volume":"8","author":"Koyama","year":"2019","journal-title":"Journal of the American Heart Association"},{"issue":"11","key":"10.1016\/j.molmet.2020.101111_bib137","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/CS20150235","article-title":"Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age","volume":"129","author":"Martino","year":"2015","journal-title":"Clinical Science"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib138","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.molmet.2020.101111_bib139","article-title":"LXR\u03b1 activation inhibits autophagy and lipophagy in hepatocytes by dysregulating ATG4B and Rab-8B, reducing mitochondrial fuel oxidation","author":"Kim","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2020.101111_bib140","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1016\/j.molmet.2020.101111_bib141","doi-asserted-by":"crossref","DOI":"10.1038\/srep13729","article-title":"Effect of MIR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2020.101111_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8466","article-title":"A\u00a0metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.molmet.2020.101111_bib143","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/jcm9072032","article-title":"Role of extracellular vesicles in the pathophysiology, diagnosis and tracking of non-alcoholic fatty liver disease","volume":"9","author":"Newman","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2020.101111_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Scientific Reports"},{"issue":"6340","key":"10.1016\/j.molmet.2020.101111_bib145","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A\u00a0subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"issue":"6220","key":"10.1016\/j.molmet.2020.101111_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.molmet.2020.101111_bib147","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3945\/jn.115.210633","article-title":"PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity","volume":"145","author":"Mondul","year":"2015","journal-title":"Journal of Nutrition"},{"issue":"8","key":"10.1016\/j.molmet.2020.101111_bib148","doi-asserted-by":"crossref","first-page":"E1125","DOI":"10.1210\/jc.2015-1587","article-title":"Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the GCKR gene","volume":"100","author":"Santoro","year":"2015","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"31","key":"10.1016\/j.molmet.2020.101111_bib149","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1073\/pnas.1410741111","article-title":"Comparative proteomic study reveals 17\u03b2-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease","volume":"111","author":"Su","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2020.101111_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102658","article-title":"Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis","volume":"52","author":"Meroni","year":"2020","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.molmet.2020.101111_bib151","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1074\/jbc.M610745200","article-title":"Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns","volume":"282","author":"Donkor","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2020.101111_bib152","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1194\/jlr.R800052-JLR200","article-title":"Lipin proteins and metabolic homeostasis","author":"Reue","year":"2009","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.molmet.2020.101111_bib153","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1\u03b1\/PPAR\u03b1 regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2020.101111_bib154","article-title":"Complex interplay between the lipin 1 and the hepatocyte nuclear factor 4 \u03b1 (HNF4\u03b1) pathways to regulate liver lipid metabolism","volume":"7","author":"Chen","year":"2012","journal-title":"PloS One"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:26:58Z","timestamp":1761956818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221287782030185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":154,"alternative-id":["S221287782030185X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101111","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and epigenetic factors determining NAFLD risk","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101111"}}